A statement by AIDS Service Organizations in Alberta, Quebec and Ontario
TORONTO, March 18 /CNW/ - A life saving post card campaign is being launched by people living with HIV/AIDS, their friends, families and service organizations in Alberta, Ontario and Quebec after the Federal government slashed community HIV funding across the country.
This HIV funding is used to provide direct services to the 62,000 Canadians living with HIV/AIDS and for implementing education programs designed to prevent new HIV infections. 2,508 Canadians were diagnosed with HIV in 2006, 14% more than were diagnosed in 2001. It is estimated that approximately 4,000 Canadians are actually newly infected with HIV each year. There still is no cure for AIDS; it continues to be a debilitating and fatal illness.
Ontario alone lost 30% of its promised federal funding with a $1 million cut in funding for programs to prevent HIV and to provide support services for people who are already infected. Quebec lost 24% of its funding and Alberta AIDS Service Organizations still have no commitment from the federal government to continue their funding which expires March 31, 2008.
AIDS Service Organizations in Alberta, Quebec and Ontario are united in urging Canadians to send a message to Prime Minister Stephen Harper and to their Members of Parliament that, Cutting Funding=Cutting Lives.
"Given a commitment by all of Canada's major political parties to double the funding by 2008 we were shocked when we learned of the cuts" said Sue Cress, Chair of the Alberta Community Council on HIV. "Alberta AIDS Service Organizations have not received an increase in funding since 2004. Instead of an expected increase this year, we will have a decrease from last year's amounts."
The Federal Initiative on HIV/AIDS promised to increase funding from $42.2 million to $84.5 million by 2008-09. The government's own figures show that $7 million will be cut from front-line service organizations at the national and regional levels over a 5 year period. These cuts are occurring as HIV/AIDS-related programs and services are experiencing dramatic increases in demand both because of the number of new infections and because people with HIV are living longer. In fact there was a 43% increase in demands for service between 1993 and 2003.
Lyse Pinault, General Director of Quebec's Coalition des Organismes Communautaires Quebecois de Lutte Contre le SIDA (COCQSIDA) stated, "Quebec has never before received a funding cut to our HIV/AIDS prevention and support services from any previous Federal government. The cost of preventing HIV is much cheaper than the cost of expensive medications to treat it."
Every HIV infection that is prevented saves approximately three quarters of a million dollars in direct and indirect costs.
On July 31, 2006, Minister of Health Tony Clement stated in a press release "...HIV/AIDS remains an issue of significant concern for Canada". Despite this assurance AIDS organizations were not given any notice that cuts were coming or a clear explanation as to why these cuts were needed. Information on the Public Health Agency of Canada's website advises that funds have been diverted to a new HIV vaccine program announced by the Prime Minister and Bill Gates on February 20, 2007.
According to Rick Kennedy, Executive Director of the Ontario AIDS Network, "Vaccine research is important for our future, but it should not come at the expense of people who are infected with HIV/AIDS. Our lives should not be any more expendable than people living with other serious health conditions. It is hard to imagine the government cutting support services for people with cancer or other very serious diseases to invest in research that may or may not prove life saving. An AIDS vaccine is many, many years into the future. What happens to our health now?"
Twenty-two years ago on December 10, 1986 a World Health Organization specialist announced that human testing of an AIDS vaccine would begin the following year. A vaccine for AIDS is still decades away. We need more vaccine research and ultimately a cure. However, Canada must not regress and reduce its efforts to prevent new HIV infections and save lives now, before a vaccine is found. Cutting Funding=Cutting Lives. Funding must be restored to the levels promised in the Federal Initiative.
We are calling on all Canadians to join us in letting the Prime Minister and his government know that these cuts are hurting Canada's ability to stop AIDS.
Send a message to the Prime Minister and Members of Parliament that HIV prevention, education and support services are important. Postcards for the "Cutting Funding=Cutting Lives" campaign can be obtained in French or English at www.increaseaidsfunding.ca
Wednesday, March 19, 2008
Tuesday, March 18, 2008
New journal received: AIDS Education and Prevention, Vol. 20, no 1, February 2008
In this issue:
Cultural Adaptation of the Focus on Kids Program for College Students in China
Authors: Xiaoming Li, Bonita Stanton, Bo Wang et al.
pp. 1-14
Abstract
HIV Serostatus Disclosure to Sexual Partners among HIV–Positive Methamphetamine-Using Gay, Bisexual, and Other Men Who Have Sex With Men
Authors: Karen C. McCready and Perry N. Halkitis
pp. 15-29
Abstract
Experiences and Sexual Behaviors of HIV–Infected MSM Who Acquired HIV in the Context of Crystal Methamphetamine Use
Authors: Matthew J. Mimiaga, Andrew D. Fair, Kenneth H. Mayer et al.
pp.30-41
Abstract
In the Shadows of a Prevention Campaign: Sexual Risk Behavior in the Absence of Crystal Methamphetamine
Authors: Christian Grov, Jeffrey T. Parsons and David S. Bimbi
pp. 42-55
Abstract
Gender Differences in Intimate Partner Violence on Substance Abuse, Sexual Risks, and Depression among a Sample of South Africans in Cape Town, South Africa
Authors: Frank Y. Wong, Z. Jennifer Huang, Julia A. DiGangi, et al.
pp. 56-64
Abstract
Self–Reported HIV Testing Behaviors among a Sample of Southeast Asians in an Urban Setting in the United States
Authors: Zhihuan Jennifer Huang, Frank Y. Wong, Jordana M. De Leon and Royce J. Park
pp. 65-77
Abstract
“Let's Talk About Sex”: Pilot Study of an Interactive CD–ROM to Prevent HIV/STIS in Female Adolescents
Authors: Kristin E. Ito, Sri Kalyanaraman, Carol A. Ford, et al.
pp 78-89
Abstract
Contact the library to request copies of articles.
Cultural Adaptation of the Focus on Kids Program for College Students in China
Authors: Xiaoming Li, Bonita Stanton, Bo Wang et al.
pp. 1-14
Abstract
HIV Serostatus Disclosure to Sexual Partners among HIV–Positive Methamphetamine-Using Gay, Bisexual, and Other Men Who Have Sex With Men
Authors: Karen C. McCready and Perry N. Halkitis
pp. 15-29
Abstract
Experiences and Sexual Behaviors of HIV–Infected MSM Who Acquired HIV in the Context of Crystal Methamphetamine Use
Authors: Matthew J. Mimiaga, Andrew D. Fair, Kenneth H. Mayer et al.
pp.30-41
Abstract
In the Shadows of a Prevention Campaign: Sexual Risk Behavior in the Absence of Crystal Methamphetamine
Authors: Christian Grov, Jeffrey T. Parsons and David S. Bimbi
pp. 42-55
Abstract
Gender Differences in Intimate Partner Violence on Substance Abuse, Sexual Risks, and Depression among a Sample of South Africans in Cape Town, South Africa
Authors: Frank Y. Wong, Z. Jennifer Huang, Julia A. DiGangi, et al.
pp. 56-64
Abstract
Self–Reported HIV Testing Behaviors among a Sample of Southeast Asians in an Urban Setting in the United States
Authors: Zhihuan Jennifer Huang, Frank Y. Wong, Jordana M. De Leon and Royce J. Park
pp. 65-77
Abstract
“Let's Talk About Sex”: Pilot Study of an Interactive CD–ROM to Prevent HIV/STIS in Female Adolescents
Authors: Kristin E. Ito, Sri Kalyanaraman, Carol A. Ford, et al.
pp 78-89
Abstract
Contact the library to request copies of articles.
The nearly forgotten plague
Source: The Globe and Mail
Cutting-edge AIDS medications have lengthened patients' lives and given many a better existence than they would have had 10 years ago, but these advances have helped push the disease out of mainstream consciousness. Health-care workers point to continuing problems that need attention: 'premature aging,' lack of bed space and failure to make sure everyone - especially the poor - gets medicine
ROD MICKLEBURGH March 15, 2008
VANCOUVER -- In the lobby of the gleaming Dr. Peter Centre for patients with AIDS, a man of indeterminate age is moaning.
"If I go out there, I'll die," he says to himself.
Another man shuffles past, his face pinched and gaunt. He looks 75 years old but isn't.
Later, a third man, Tom Griffin, came into a room to talk. Or rather, he was wheeled in by his friend, Spencer Dane. He has difficulty keeping his head up. His voice is weak. Conversation often drops off from fatigue and emotion. And this is a good day for the once-vigorous restaurateur, Mr. Dane said.
It's a face of AIDS not seen much any more. As breakthrough medications lengthen lives, saving tens of thousands of infected Canadians from a terrible, premature death, the news media have moved on to other stories. But a visit to Dr. Peter's, or a talk with anyone on the treatment front lines, is a sobering reminder that Old Man AIDS, the deadly viral trickster, hasn't gone away. People are still being infected, still suffering and still dying.
The picture is not pretty. Although more people than ever before are living with AIDS and HIV, many are far from healthy. Woeful gaps in care remain, between those stable enough to maintain life-prolonging antiretroviral therapy and those who remain on the wild side. Despite the best efforts of dedicated outreach workers and physicians, 40 per cent of the 1,436 British Columbians who died of HIV-related causes from 1997 to 2005 made no attempt to access the drugs, even though they were free.
Another 2,500 individuals in B.C. are estimated to be HIV-positive without knowing it, greatly increasing the risk of passing the lethal virus on to others. (...)
Click here to read the complete article.
Cutting-edge AIDS medications have lengthened patients' lives and given many a better existence than they would have had 10 years ago, but these advances have helped push the disease out of mainstream consciousness. Health-care workers point to continuing problems that need attention: 'premature aging,' lack of bed space and failure to make sure everyone - especially the poor - gets medicine
ROD MICKLEBURGH March 15, 2008
VANCOUVER -- In the lobby of the gleaming Dr. Peter Centre for patients with AIDS, a man of indeterminate age is moaning.
"If I go out there, I'll die," he says to himself.
Another man shuffles past, his face pinched and gaunt. He looks 75 years old but isn't.
Later, a third man, Tom Griffin, came into a room to talk. Or rather, he was wheeled in by his friend, Spencer Dane. He has difficulty keeping his head up. His voice is weak. Conversation often drops off from fatigue and emotion. And this is a good day for the once-vigorous restaurateur, Mr. Dane said.
It's a face of AIDS not seen much any more. As breakthrough medications lengthen lives, saving tens of thousands of infected Canadians from a terrible, premature death, the news media have moved on to other stories. But a visit to Dr. Peter's, or a talk with anyone on the treatment front lines, is a sobering reminder that Old Man AIDS, the deadly viral trickster, hasn't gone away. People are still being infected, still suffering and still dying.
The picture is not pretty. Although more people than ever before are living with AIDS and HIV, many are far from healthy. Woeful gaps in care remain, between those stable enough to maintain life-prolonging antiretroviral therapy and those who remain on the wild side. Despite the best efforts of dedicated outreach workers and physicians, 40 per cent of the 1,436 British Columbians who died of HIV-related causes from 1997 to 2005 made no attempt to access the drugs, even though they were free.
Another 2,500 individuals in B.C. are estimated to be HIV-positive without knowing it, greatly increasing the risk of passing the lethal virus on to others. (...)
Click here to read the complete article.
Study uncovers HIV 'mini-epidemics'
Source: Channel 4 News
HIV is spreading among gay men in mini-epidemics, a study has found.
Data from more than 2,000 infected men in London showed distinct clusters or "bursts" of the disease.
Researchers now believe targeted local campaigns in bars, nightclubs and via the internet could be the most effective way of curbing the spread of the disease by sexual contact.
The University of Edinburgh study was carried out with Chelsea and Westminster Hospital in London, using data collected between 1997 and 2003. It found many men who became infected with the virus passed it on within a few months, often before they themselves had been diagnosed as HIV positive.
Professor Andrew Leigh Brown of the University of Edinburgh's School of Biological Sciences, who led the study, said: "By studying changes in the virus over time, we have been able to pinpoint its progress in stages through the groups of men affected, which until now has not been done effectively. What we have discovered is that some of the spread occurred in bursts, with groups of people becoming infected within a short period of time."
Prof Leigh Brown said such a pattern had been seen occasionally among HIV-infected drug users but had not been identified in sexual transmission until now. (...)
The study is published in PLoS Medicine. Click here to access it.
HIV is spreading among gay men in mini-epidemics, a study has found.
Data from more than 2,000 infected men in London showed distinct clusters or "bursts" of the disease.
Researchers now believe targeted local campaigns in bars, nightclubs and via the internet could be the most effective way of curbing the spread of the disease by sexual contact.
The University of Edinburgh study was carried out with Chelsea and Westminster Hospital in London, using data collected between 1997 and 2003. It found many men who became infected with the virus passed it on within a few months, often before they themselves had been diagnosed as HIV positive.
Professor Andrew Leigh Brown of the University of Edinburgh's School of Biological Sciences, who led the study, said: "By studying changes in the virus over time, we have been able to pinpoint its progress in stages through the groups of men affected, which until now has not been done effectively. What we have discovered is that some of the spread occurred in bursts, with groups of people becoming infected within a short period of time."
Prof Leigh Brown said such a pattern had been seen occasionally among HIV-infected drug users but had not been identified in sexual transmission until now. (...)
The study is published in PLoS Medicine. Click here to access it.
Monday, March 17, 2008
Manitoba HIV rate almost quadruples among women
Source: CBC News
The rate of HIV infection is rising dramatically in Manitoba among women and First Nations communities, according to a new report by Manitoba Health. The proportion of newly diagnosed HIV cases among women has almost quadrupled in the past decade, compared with the previous one, the report says.
Of cases where the ethnicity of the patient is reported, one-third of all new infections were diagnosed in aboriginal people in the past seven years. Dr. Pierre Plourde, medical officer of health for the Winnipeg Regional Health Authority, said one reason for the increase could be a change in attitude about HIV (the human immunodeficiency virus).
"We think that one of the reasons for that could be that HIV has now become seen as just a chronic condition that is manageable," he said.
"It's not the death sentence it used to be, and people's sexual behaviours are reflecting that now. There are much more risky sexual behaviours occurring in men and in women."
The trend for HIV infection on Manitoba First Nations appears to be mimicking the way infection has spread across sub-Saharan Africa, Plourde said.
Like sub-Saharan Africa
"If you look at the numbers among First Nations, the ratio of men-to-women cases is almost equal, which is more reflective of the type of dynamic that is seen in sub-Saharan Africa, suggesting similar forms of transmission, i.e. men and women transmitting it to one another through sexual means," he said.
Between 1985 and 1995, about 65 per cent of new HIV cases were believed to have been transmitted among men having sex with men, the report says, while reported heterosexual transmissions made up just nine per cent. But in cases reported in the past decade, homosexual transmission cases had dropped to 18 per cent, while heterosexual transmission cases climbed to 32 per cent. Women accounted for a third of all new HIV cases in the past decade, compared with eight per cent in the previous one. Of the cases over the past seven years in which ethnicity of the patient was reported, 32 per cent of patients said they were aboriginal, 27 per cent white, and 20 per cent black. The number of people infected with HIV in Manitoba is still very low compared with other countries, Plourde said, but Manitoba has one of the highest per-capita rates of HIV infection in Canada.
82 new cases in 2007
A total of 1,477 people in Manitoba tested positive for HIV between 1985 and the end of 2007, according to the report. Eighty-two new cases were reported in 2007. More than 260 cases of AIDS have been reported since 1985, the report says; nearly three-quarters of them have died. More than 80 per cent of all HIV cases were reported among residents of Winnipeg. Positive HIV test results must, by law, be reported to provincial officials. AIDS cases and deaths are also reportable.
Last year, the provincial government made it possible for Manitobans to be tested anonymously for HIV and other sexually transmitted infections, a move that was expected to encourage people who otherwise might not have been tested to do so.
The rate of HIV infection is rising dramatically in Manitoba among women and First Nations communities, according to a new report by Manitoba Health. The proportion of newly diagnosed HIV cases among women has almost quadrupled in the past decade, compared with the previous one, the report says.
Of cases where the ethnicity of the patient is reported, one-third of all new infections were diagnosed in aboriginal people in the past seven years. Dr. Pierre Plourde, medical officer of health for the Winnipeg Regional Health Authority, said one reason for the increase could be a change in attitude about HIV (the human immunodeficiency virus).
"We think that one of the reasons for that could be that HIV has now become seen as just a chronic condition that is manageable," he said.
"It's not the death sentence it used to be, and people's sexual behaviours are reflecting that now. There are much more risky sexual behaviours occurring in men and in women."
The trend for HIV infection on Manitoba First Nations appears to be mimicking the way infection has spread across sub-Saharan Africa, Plourde said.
Like sub-Saharan Africa
"If you look at the numbers among First Nations, the ratio of men-to-women cases is almost equal, which is more reflective of the type of dynamic that is seen in sub-Saharan Africa, suggesting similar forms of transmission, i.e. men and women transmitting it to one another through sexual means," he said.
Between 1985 and 1995, about 65 per cent of new HIV cases were believed to have been transmitted among men having sex with men, the report says, while reported heterosexual transmissions made up just nine per cent. But in cases reported in the past decade, homosexual transmission cases had dropped to 18 per cent, while heterosexual transmission cases climbed to 32 per cent. Women accounted for a third of all new HIV cases in the past decade, compared with eight per cent in the previous one. Of the cases over the past seven years in which ethnicity of the patient was reported, 32 per cent of patients said they were aboriginal, 27 per cent white, and 20 per cent black. The number of people infected with HIV in Manitoba is still very low compared with other countries, Plourde said, but Manitoba has one of the highest per-capita rates of HIV infection in Canada.
82 new cases in 2007
A total of 1,477 people in Manitoba tested positive for HIV between 1985 and the end of 2007, according to the report. Eighty-two new cases were reported in 2007. More than 260 cases of AIDS have been reported since 1985, the report says; nearly three-quarters of them have died. More than 80 per cent of all HIV cases were reported among residents of Winnipeg. Positive HIV test results must, by law, be reported to provincial officials. AIDS cases and deaths are also reportable.
Last year, the provincial government made it possible for Manitobans to be tested anonymously for HIV and other sexually transmitted infections, a move that was expected to encourage people who otherwise might not have been tested to do so.
Wednesday, March 05, 2008
HIV infections expected to rise
Source: ABC News
A study focusing on HIV infection trends in Australian gay men is predicting a substantial increase in HIV infection in some states over the next seven years.
The report released today by the National Centre in HIV Epidemiology and Clinical Research predicts a 73 per cent rise in HIV infections in Victoria and a 20 per cent rise in Queensland by 2015.
But the infection rate is predicted to show a slight decrease in New South Wales.
Researcher Dr David Wilson says reduced condom usage and a rise in other sexually transmitted diseases is expected to contribute to the increase.
"If somebody's HIV positive and have another infection such as syphilis, gonorrhoea, chlamydia, herpes, then they are 200 to 500 per cent more likely to transmit HIV to a susceptible person," he said.
Dr Wilson says increased promotion of safe sex is the most effective way to stop the rise HIV transmission.
A study focusing on HIV infection trends in Australian gay men is predicting a substantial increase in HIV infection in some states over the next seven years.
The report released today by the National Centre in HIV Epidemiology and Clinical Research predicts a 73 per cent rise in HIV infections in Victoria and a 20 per cent rise in Queensland by 2015.
But the infection rate is predicted to show a slight decrease in New South Wales.
Researcher Dr David Wilson says reduced condom usage and a rise in other sexually transmitted diseases is expected to contribute to the increase.
"If somebody's HIV positive and have another infection such as syphilis, gonorrhoea, chlamydia, herpes, then they are 200 to 500 per cent more likely to transmit HIV to a susceptible person," he said.
Dr Wilson says increased promotion of safe sex is the most effective way to stop the rise HIV transmission.
Monday, March 03, 2008
Gene could stop spread of HIV
Source: The Edmonton Sun
New research reveals from U of A
By KEVIN CRUSH, SUN MEDIA
New research out of the University of Alberta shows that a gene found in the human body could be used to stop the spread of HIV.
“It’s very exciting for patients who are infected with HIV,” said researcher Dr. Stephen Barr. “It gives them another target or hope that there is another gene that can help them out in their fight.”
News that there could be another weapon against HIV/AIDS is indeed a big deal, said Debra Jakubec, executive director of HIV Edmonton.
“It’s exciting research. It is still probably a far ways from getting it out of clinical research but it is exciting,” added Jakubec.
Three years ago while at the University of Pennsylvania, Barr, 32, began his work on a gene called TRIM22 – work that continued when he moved to the University of Alberta’s department of medical microbiology and immunology two years ago.
TRIM22 is a gene in humans that fights viruses. For a reason still unknown, TRIM22 doesn’t work in patients with Human Immunodeficiency Virus (HIV).
But lab tests have shown that when TRIM22 is turned on in cell cultures infected with HIV, the gene stops the assembly of the virus and essentially locks the virus in the cell like a prisoner in a cage. If it can’t get out of the cell, the spread of HIV is stopped in its tracks.
“This gene works particularly at preventing the virus from getting out of cells. So it can’t stop the virus from getting in (to the cell) but it can lock it in so it can’t get out,” said Barr, whose research is being published in the medical journal PloS Pathogens.
It’s not a cure, cautioned Barr. It hasn’t been tried in live patients so it’s not known if TRIM22 could be turned on in a person or what would happen, but it could be a major step towards finding a cure.
“One hope is that if you can trap the virus in the cell, other defence mechanisms in the cell will try to get rid of it,” said Barr.
Another possibility is researchers may be able to develop drugs that mimic TRIM22 to be used to block the spread of HIV or even to possibly cure it.
“If we include TRIM22 in our therapies, it can be used in combination with drugs to make them more effective at blocking and killing the virus,” said Barr.
Jakubec is hopeful this research will help in finding a cure or vaccine, but she also cautions that cure is still a long ways off.
“If something does come out that’s a preventative vaccine, we would still want people to know just how effective it is and still practice safer sex,” she said.
She noted that Alberta is seeing rising rates of sexually transmitted diseases such as gonorrhea and syphilis. Even the number of HIV infections in Alberta appears to be on the rise. New infections in the province used to average 170-180 per year, but in 2006 that rose to 218.
Barr is also cautioning that this is just a step in the fight against AIDS.
“We’re really in the infancy of the research. This is the initial discovery and we need to go in and find out how the virus is interacting with TRIM22, such as does the virus have a way of killing TRIM22 so that it can survive?”
New research reveals from U of A
By KEVIN CRUSH, SUN MEDIA
New research out of the University of Alberta shows that a gene found in the human body could be used to stop the spread of HIV.
“It’s very exciting for patients who are infected with HIV,” said researcher Dr. Stephen Barr. “It gives them another target or hope that there is another gene that can help them out in their fight.”
News that there could be another weapon against HIV/AIDS is indeed a big deal, said Debra Jakubec, executive director of HIV Edmonton.
“It’s exciting research. It is still probably a far ways from getting it out of clinical research but it is exciting,” added Jakubec.
Three years ago while at the University of Pennsylvania, Barr, 32, began his work on a gene called TRIM22 – work that continued when he moved to the University of Alberta’s department of medical microbiology and immunology two years ago.
TRIM22 is a gene in humans that fights viruses. For a reason still unknown, TRIM22 doesn’t work in patients with Human Immunodeficiency Virus (HIV).
But lab tests have shown that when TRIM22 is turned on in cell cultures infected with HIV, the gene stops the assembly of the virus and essentially locks the virus in the cell like a prisoner in a cage. If it can’t get out of the cell, the spread of HIV is stopped in its tracks.
“This gene works particularly at preventing the virus from getting out of cells. So it can’t stop the virus from getting in (to the cell) but it can lock it in so it can’t get out,” said Barr, whose research is being published in the medical journal PloS Pathogens.
It’s not a cure, cautioned Barr. It hasn’t been tried in live patients so it’s not known if TRIM22 could be turned on in a person or what would happen, but it could be a major step towards finding a cure.
“One hope is that if you can trap the virus in the cell, other defence mechanisms in the cell will try to get rid of it,” said Barr.
Another possibility is researchers may be able to develop drugs that mimic TRIM22 to be used to block the spread of HIV or even to possibly cure it.
“If we include TRIM22 in our therapies, it can be used in combination with drugs to make them more effective at blocking and killing the virus,” said Barr.
Jakubec is hopeful this research will help in finding a cure or vaccine, but she also cautions that cure is still a long ways off.
“If something does come out that’s a preventative vaccine, we would still want people to know just how effective it is and still practice safer sex,” she said.
She noted that Alberta is seeing rising rates of sexually transmitted diseases such as gonorrhea and syphilis. Even the number of HIV infections in Alberta appears to be on the rise. New infections in the province used to average 170-180 per year, but in 2006 that rose to 218.
Barr is also cautioning that this is just a step in the fight against AIDS.
“We’re really in the infancy of the research. This is the initial discovery and we need to go in and find out how the virus is interacting with TRIM22, such as does the virus have a way of killing TRIM22 so that it can survive?”
Zimbabwe: Canada Donates C$2,4m for HIV/Aids Project
Source: All Africa
Harare
THE Canadian government on Wednesday injected C$2,4 million into the Expanded Support Programme for HIV and Aids Prevention, Treatment and Care in Zimbabwe while the Conglomerate of Farm and Industry has launched an HIV programme for the workplace.
ESP, an initiative of the United Nations Development Programme, has 16 districts in Zimbabwe. The Zimbabwe National HIV and Aids Strategic Plan will also benefit from the donation.
Canadian Ambassador to Zimbabwe Mrs Roxanne Dubé handed over the money to UNDP on Wednesday in Harare. UNDP will then disburse the money to ESP's 16 districts for the benefit of about 20 000 people, most of them in rural areas. Speaking at the handover ceremony, Mrs Dubé hailed Zimbabweans for their efforts in to curb the incidence of HIV and Aids. "I appreciate the work being done by Zimbabweans and other stakeholders in addressing the prevalence of HIV and Aids in the country," she said.
Mrs Dubé said the donation would not only help to support the infected with drugs, prevention services, treatment and care but also the ESP.
"As partners in development, Canada is concerned with the welfare of the people of Zimbabwe. On issues of such critical humanitarian importance and for the direct benefit of the most vulnerable people, we are pleased to collaborate with the dedicated staff in both civil society and the national health system in rural and urban Zimbabwe," she said.
Ambassador Dubé said the initiative was consistent with the government of Canada's priorities to scale up universal access to HIV and Aids services reiterated at the United Nations General Assembly Special Session on HIV and Aids of 2006. National Aids Council director Dr Tapiwa Magure hailed Canada for its continued support in the national multi-sectoral response to HIV and Aids.
Meanwhile, the Conglomerate of Farms and Industry has launched a programme of HIV and Aids awareness in the workplace in Harare. CFI comprises 12 companies, among them Town and Country, Farm and City, Victoria Foods, Suncrest, Hubbard, Agrifoods as well as Dore and Pitt.
CFI group human resources director Mr Edwin Murwira said they launched the awareness programme because the rate at which people were perishing at workplaces on farms and in industry had reached alarming levels. He said they were not going to assist financially as yet because people needed to be taught first.
"We want people to know that they must abstain, use condoms or be faithful to thwart the spread of HIV and Aids in the workplace," he said.
Although Mr Murwira said the programme was the first of its kind, he expressed confidence that it would yield beneficial results. Speaking at the same workshop, National Aids Council finance director Mr Albert Manenji challenged the business community to help in HIV and Aids issues.
"NAC needs US$38 million to procure anti-retroviral drugs," he said.
Harare
THE Canadian government on Wednesday injected C$2,4 million into the Expanded Support Programme for HIV and Aids Prevention, Treatment and Care in Zimbabwe while the Conglomerate of Farm and Industry has launched an HIV programme for the workplace.
ESP, an initiative of the United Nations Development Programme, has 16 districts in Zimbabwe. The Zimbabwe National HIV and Aids Strategic Plan will also benefit from the donation.
Canadian Ambassador to Zimbabwe Mrs Roxanne Dubé handed over the money to UNDP on Wednesday in Harare. UNDP will then disburse the money to ESP's 16 districts for the benefit of about 20 000 people, most of them in rural areas. Speaking at the handover ceremony, Mrs Dubé hailed Zimbabweans for their efforts in to curb the incidence of HIV and Aids. "I appreciate the work being done by Zimbabweans and other stakeholders in addressing the prevalence of HIV and Aids in the country," she said.
Mrs Dubé said the donation would not only help to support the infected with drugs, prevention services, treatment and care but also the ESP.
"As partners in development, Canada is concerned with the welfare of the people of Zimbabwe. On issues of such critical humanitarian importance and for the direct benefit of the most vulnerable people, we are pleased to collaborate with the dedicated staff in both civil society and the national health system in rural and urban Zimbabwe," she said.
Ambassador Dubé said the initiative was consistent with the government of Canada's priorities to scale up universal access to HIV and Aids services reiterated at the United Nations General Assembly Special Session on HIV and Aids of 2006. National Aids Council director Dr Tapiwa Magure hailed Canada for its continued support in the national multi-sectoral response to HIV and Aids.
Meanwhile, the Conglomerate of Farms and Industry has launched a programme of HIV and Aids awareness in the workplace in Harare. CFI comprises 12 companies, among them Town and Country, Farm and City, Victoria Foods, Suncrest, Hubbard, Agrifoods as well as Dore and Pitt.
CFI group human resources director Mr Edwin Murwira said they launched the awareness programme because the rate at which people were perishing at workplaces on farms and in industry had reached alarming levels. He said they were not going to assist financially as yet because people needed to be taught first.
"We want people to know that they must abstain, use condoms or be faithful to thwart the spread of HIV and Aids in the workplace," he said.
Although Mr Murwira said the programme was the first of its kind, he expressed confidence that it would yield beneficial results. Speaking at the same workshop, National Aids Council finance director Mr Albert Manenji challenged the business community to help in HIV and Aids issues.
"NAC needs US$38 million to procure anti-retroviral drugs," he said.
Thursday, February 28, 2008
New journal received in the library: AIDS Patient Care& STDs, Vol. 22, no 1, January 2008
In this issue:
Case Report: Bilateral Renal Aspergillosis in a Patient with AIDS: A Case Report and Review of Reported Cases
A.W. Oosten, H.G. Sprenger, J.T.M. van Leeuwen, N.E.L. Meessen, S. van Assen
pp. 1-6.
Abstract
Viro-Immunologic Response to Ritonavir-Boosted or Unboosted Atazanavir in a Large Cohort of Multiply Treated Patients: The CARe Study
Maria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, Adriano Lazzarin, Roberto Esposito, Giampiero Carosi, Giovanni Di Perri, Gaetano Filice, Mauro Moroni, Giuliano Rizzardini, Pietro Caramello, Renato Maserati, Pasquale Narciso, Antonietta Cargnel, Andrea Antinori, Carlo Federico Perno, the CARe Study Group
pp. 7-16.
Abstract
Concurrent HIV/AIDS Diagnosis Increases the Risk of Short-Term HIV-Related Death among Persons Newly Diagnosed with AIDS, 2002–2005
David B. Hanna, Melissa R. Pfeiffer, Lucia V. Torian, Judith E. Sackoff
pp. 17-28.
Abstract
Prior Illicit Drug Use and Missed Prenatal Vitamins Predict Nonadherence to Antiretroviral Therapy in Pregnancy: Adherence Analysis A5084
Susan E. Cohn, Triin Umbleja, Joseph Mrus, Arlene D. Bardeguez, Janet W. Andersen, Margaret A. Chesney
pp. 29-40.
Abstract
Predictors of the Initiation of HIV Postexposure Prophylaxis in Rhode Island Emergency Departments
Roland C. Merchant, Kenneth H. Mayer, Bruce M. Becker, Allison K. Delong, Joseph W. Hogan
pp. 41-52.
Abstract
A Qualitative Study Among Injection Drug Using Women in Rhode Island: Attitudes Toward Testing, Treatment, and Vaccination for Hepatitis and HIV
Michelle A. Lally, Sydney A. Montstream-Quas, Sara Tanaka, Sara K. Tedeschi, Kathleen M. Morrow
pp. 53-64.
Abstract
Vaccination in Brazilian HIV-Infected Adults: A Cross-Sectional Study
Yeh Li Ho, Thatiana Enohata, Marta Heloisa Lopes, Sigrid De Sousa Dos Santos
pp. 65-70.
Abstract
Self-Reported Adherence to Antiretroviral Treatment among HIV-Infected People in Central China
Honghong Wang, Gouping He, Xianhong Li, Aiyun Yang, Xi Chen, Kristopher P. Fennie, Ann Bartley Williams
pp. 71-80.
Abstract
Letter to the Editor: Medical Care of HIV-Infected Individuals in Poland: Impact of Stigmatization by Health Care Workers
Dorota Rogowska-Szadkowska, Alicja Małgorzata Ołtarzewska, Jolanta Sawicka-Powierza, Sławomir Chlabicz
pp. 81-84.
Contact the library to request copies of articles.
Case Report: Bilateral Renal Aspergillosis in a Patient with AIDS: A Case Report and Review of Reported Cases
A.W. Oosten, H.G. Sprenger, J.T.M. van Leeuwen, N.E.L. Meessen, S. van Assen
pp. 1-6.
Abstract
Viro-Immunologic Response to Ritonavir-Boosted or Unboosted Atazanavir in a Large Cohort of Multiply Treated Patients: The CARe Study
Maria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, Adriano Lazzarin, Roberto Esposito, Giampiero Carosi, Giovanni Di Perri, Gaetano Filice, Mauro Moroni, Giuliano Rizzardini, Pietro Caramello, Renato Maserati, Pasquale Narciso, Antonietta Cargnel, Andrea Antinori, Carlo Federico Perno, the CARe Study Group
pp. 7-16.
Abstract
Concurrent HIV/AIDS Diagnosis Increases the Risk of Short-Term HIV-Related Death among Persons Newly Diagnosed with AIDS, 2002–2005
David B. Hanna, Melissa R. Pfeiffer, Lucia V. Torian, Judith E. Sackoff
pp. 17-28.
Abstract
Prior Illicit Drug Use and Missed Prenatal Vitamins Predict Nonadherence to Antiretroviral Therapy in Pregnancy: Adherence Analysis A5084
Susan E. Cohn, Triin Umbleja, Joseph Mrus, Arlene D. Bardeguez, Janet W. Andersen, Margaret A. Chesney
pp. 29-40.
Abstract
Predictors of the Initiation of HIV Postexposure Prophylaxis in Rhode Island Emergency Departments
Roland C. Merchant, Kenneth H. Mayer, Bruce M. Becker, Allison K. Delong, Joseph W. Hogan
pp. 41-52.
Abstract
A Qualitative Study Among Injection Drug Using Women in Rhode Island: Attitudes Toward Testing, Treatment, and Vaccination for Hepatitis and HIV
Michelle A. Lally, Sydney A. Montstream-Quas, Sara Tanaka, Sara K. Tedeschi, Kathleen M. Morrow
pp. 53-64.
Abstract
Vaccination in Brazilian HIV-Infected Adults: A Cross-Sectional Study
Yeh Li Ho, Thatiana Enohata, Marta Heloisa Lopes, Sigrid De Sousa Dos Santos
pp. 65-70.
Abstract
Self-Reported Adherence to Antiretroviral Treatment among HIV-Infected People in Central China
Honghong Wang, Gouping He, Xianhong Li, Aiyun Yang, Xi Chen, Kristopher P. Fennie, Ann Bartley Williams
pp. 71-80.
Abstract
Letter to the Editor: Medical Care of HIV-Infected Individuals in Poland: Impact of Stigmatization by Health Care Workers
Dorota Rogowska-Szadkowska, Alicja Małgorzata Ołtarzewska, Jolanta Sawicka-Powierza, Sławomir Chlabicz
pp. 81-84.
Contact the library to request copies of articles.
New approach stops HIV at earliest stage of infection
Source: Science Daily
ScienceDaily (Feb. 28, 2008) — Researchers at The Scripps Research Institute have developed a new two-punch strategy against HIV and they have already successfully tested aspects of it in the laboratory.
Their study, which appears in the online Early Edition of the Proceedings of the National Academy of Sciences, may re-energize attempts to create a preventive/therapeutic vaccine against HIV, say the authors. To date, more than a dozen candidate vaccines, which have attempted to raise immunity against the spiky proteins on the viral envelope, have all failed in clinical testing.
The investigators have created devices they call glycodendrons that are designed to do two things at once: inhibit the transport of HIV from where it traditionally enters the body, preventing it from moving deeper inside where it can infect immune cells; and set up an immune antibody response to a unique carbohydrate structure on the surface of the virus.
"This paper is about a new direction in HIV vaccine design," said the study's lead investigator, Scripps Research Chemistry Professor Chi-Huey Wong. "Results we have so far are very promising."
To date, he says the devices have been able to stimulate the immune system of mice to induce antibodies against HIV surface glycoprotein, and, in laboratory studies, have been able to block the virus from infecting immune cells. (...)
Click here to read the complete article.
ScienceDaily (Feb. 28, 2008) — Researchers at The Scripps Research Institute have developed a new two-punch strategy against HIV and they have already successfully tested aspects of it in the laboratory.
Their study, which appears in the online Early Edition of the Proceedings of the National Academy of Sciences, may re-energize attempts to create a preventive/therapeutic vaccine against HIV, say the authors. To date, more than a dozen candidate vaccines, which have attempted to raise immunity against the spiky proteins on the viral envelope, have all failed in clinical testing.
The investigators have created devices they call glycodendrons that are designed to do two things at once: inhibit the transport of HIV from where it traditionally enters the body, preventing it from moving deeper inside where it can infect immune cells; and set up an immune antibody response to a unique carbohydrate structure on the surface of the virus.
"This paper is about a new direction in HIV vaccine design," said the study's lead investigator, Scripps Research Chemistry Professor Chi-Huey Wong. "Results we have so far are very promising."
To date, he says the devices have been able to stimulate the immune system of mice to induce antibodies against HIV surface glycoprotein, and, in laboratory studies, have been able to block the virus from infecting immune cells. (...)
Click here to read the complete article.
Monday, February 25, 2008
B.C. study shows 40 per cent of HIV sufferers died without getting treatment
Source: The Canadian Press
VANCOUVER - Forty per cent of the people who died of HIV-AIDS in British Columbia never accessed life-saving treatment even though it was free, according to a new study released Friday.
The study by the B.C. Centre for Excellence in HIV-AIDS looked into more than 1,400 HIV-related deaths in the province between 1997 and 2005.
In that period of time, a total of 567 people died without ever receiving the highly effective antiretroviral treatment.
"We have a problem," said Dr. Julio Montaner, director of the centre. "The treatments are available for free but something is wrong because the people that most need the treatment, they're not always accessing the treatment."
Low income was strongly associated with the delay in starting therapy and the ensuing high mortality rate.
Residence in a poor neighbourhood was associated with an increased risk of mortality among HIV patients, Montaner said.
"Factors such as a lack of housing or transportation, mental illness, illegal activity and language barriers play a role in an individual's ability to access treatment," he said.
Twenty-five per cent of those infected with HIV in Canada are not aware of their infection, according to the centre.
The centre distributes the cocktail of antiretroviral medications to all eligible British Columbians, free of charge, through the provincewide Drug Treatment Program, funded by Pharmacare.
Yet ensuring access to the treatment remains an elusive goal, he said.
"We have found that over the last several years there is a persistent number of people dying with HIV in our midst, where treatment and health care is supposed to be readily available," Montaner said.
Typical examples are single mothers who don't have the resources to get a babysitter or a homeless, mentally ill drug addict who lives on the Downtown Eastside and doesn't even know he's HIV-positive, he said.
And it's not just Vancouver, Montaner said. It's a problem right across the country and the percentage could even be worse in smaller communities where fewer resources are available.
Ann Livingston, spokeswoman for the Vancouver Area Network of Drug Users, called the study shocking.
Four in 10 people in Vancouver's Downtown Eastside live outside and many among them are sick with AIDS, she said.
Some live in substandard hotels that are often infested with cockroaches and unsafe but people stay there because welfare payments don't provide enough money for decent housing for those who are too ill to work, Livingston said.
"And they have no general practitioner. That's another nightmare," she said.
Ken Buchanan, of the British Columbia Persons with AIDS Society, said the long-term solution is to bring some stability to the lives of HIV-AIDS sufferers.
"For a person who is homeless, taking medications, even free medications, is pretty low in their priorities," he said.
Buchanan warned that access to medication isn't enough. A person who begins treatment and doesn't maintain the proper dose regime will build up a resistance to the drugs and end up more likely to die.
"You can't take them for a few days and then stop for a few days," he said. "If your life is chaotic ... you don't have the ability or the need or the desire to take your meds."
The centre has a proposal before the provincial government to form outreach teams that would take rapid-response testing to the most vulnerable and offer treatment.
But "free health care is not necessarily enough to address this problem," he said.
"We need to bring the treatments to the people and we need to create the programs that are going to help these individuals to take the treatment," he said.
It is not only the ethical and human thing to do, he said, it's also better for society at large because it reduces HIV-related illnesses that drain the health care system.
"By treating these people we're doing what is right for them, we're doing what is right for the system and we're also going to decrease HIV transmission," Montaner said.
"This is the right thing to do both in an ethical sense and also in a business sense."
Previous research by the centre and by researchers in Taiwan showed a 50 per cent reduction in new HIV cases that they felt was due to access to the highly active antiretroviral therapy.
The treatment consists of three or more antiretroviral drugs on a daily basis for life and it requires a very high level of adherence in order to be fully effective.
It has been the standard of care for the treatment of HIV-AIDS since 1996.
VANCOUVER - Forty per cent of the people who died of HIV-AIDS in British Columbia never accessed life-saving treatment even though it was free, according to a new study released Friday.
The study by the B.C. Centre for Excellence in HIV-AIDS looked into more than 1,400 HIV-related deaths in the province between 1997 and 2005.
In that period of time, a total of 567 people died without ever receiving the highly effective antiretroviral treatment.
"We have a problem," said Dr. Julio Montaner, director of the centre. "The treatments are available for free but something is wrong because the people that most need the treatment, they're not always accessing the treatment."
Low income was strongly associated with the delay in starting therapy and the ensuing high mortality rate.
Residence in a poor neighbourhood was associated with an increased risk of mortality among HIV patients, Montaner said.
"Factors such as a lack of housing or transportation, mental illness, illegal activity and language barriers play a role in an individual's ability to access treatment," he said.
Twenty-five per cent of those infected with HIV in Canada are not aware of their infection, according to the centre.
The centre distributes the cocktail of antiretroviral medications to all eligible British Columbians, free of charge, through the provincewide Drug Treatment Program, funded by Pharmacare.
Yet ensuring access to the treatment remains an elusive goal, he said.
"We have found that over the last several years there is a persistent number of people dying with HIV in our midst, where treatment and health care is supposed to be readily available," Montaner said.
Typical examples are single mothers who don't have the resources to get a babysitter or a homeless, mentally ill drug addict who lives on the Downtown Eastside and doesn't even know he's HIV-positive, he said.
And it's not just Vancouver, Montaner said. It's a problem right across the country and the percentage could even be worse in smaller communities where fewer resources are available.
Ann Livingston, spokeswoman for the Vancouver Area Network of Drug Users, called the study shocking.
Four in 10 people in Vancouver's Downtown Eastside live outside and many among them are sick with AIDS, she said.
Some live in substandard hotels that are often infested with cockroaches and unsafe but people stay there because welfare payments don't provide enough money for decent housing for those who are too ill to work, Livingston said.
"And they have no general practitioner. That's another nightmare," she said.
Ken Buchanan, of the British Columbia Persons with AIDS Society, said the long-term solution is to bring some stability to the lives of HIV-AIDS sufferers.
"For a person who is homeless, taking medications, even free medications, is pretty low in their priorities," he said.
Buchanan warned that access to medication isn't enough. A person who begins treatment and doesn't maintain the proper dose regime will build up a resistance to the drugs and end up more likely to die.
"You can't take them for a few days and then stop for a few days," he said. "If your life is chaotic ... you don't have the ability or the need or the desire to take your meds."
The centre has a proposal before the provincial government to form outreach teams that would take rapid-response testing to the most vulnerable and offer treatment.
But "free health care is not necessarily enough to address this problem," he said.
"We need to bring the treatments to the people and we need to create the programs that are going to help these individuals to take the treatment," he said.
It is not only the ethical and human thing to do, he said, it's also better for society at large because it reduces HIV-related illnesses that drain the health care system.
"By treating these people we're doing what is right for them, we're doing what is right for the system and we're also going to decrease HIV transmission," Montaner said.
"This is the right thing to do both in an ethical sense and also in a business sense."
Previous research by the centre and by researchers in Taiwan showed a 50 per cent reduction in new HIV cases that they felt was due to access to the highly active antiretroviral therapy.
The treatment consists of three or more antiretroviral drugs on a daily basis for life and it requires a very high level of adherence in order to be fully effective.
It has been the standard of care for the treatment of HIV-AIDS since 1996.
Monday, February 18, 2008
Study: Gel Fails to Stop HIV Infection
Source: The Associated Press
The first anti-AIDS vaginal gel to make it through late-stage testing failed to stop HIV infection in a study of 6,000 South African women, disappointed researchers announced Monday.
The study was marred by low use of the gel, which could have undermined results, they said. Women used it less than half the number of times they had sex, and only 10 percent said they used it every time as directed.
Scientists are still analyzing the results to see if this made a difference. They also plan more tests on a revamped gel containing an AIDS drug that they hope will work better.
The gel used in the current study did prove safe, however, and researchers called that a watershed event.
But for now, the effort is the latest disappointment in two decades of trying to develop a microbicide — a cream or gel women could use to lower their risk of getting HIV through sex. A female-controlled method is especially needed in poor countries where women often can't persuade men to use condoms.
A year ago, scientists stopped two late-stage tests of a different gel after early results suggested it might raise the risk of HIV infection instead of lowering it. (...)
Click here to read the complete article.
The first anti-AIDS vaginal gel to make it through late-stage testing failed to stop HIV infection in a study of 6,000 South African women, disappointed researchers announced Monday.
The study was marred by low use of the gel, which could have undermined results, they said. Women used it less than half the number of times they had sex, and only 10 percent said they used it every time as directed.
Scientists are still analyzing the results to see if this made a difference. They also plan more tests on a revamped gel containing an AIDS drug that they hope will work better.
The gel used in the current study did prove safe, however, and researchers called that a watershed event.
But for now, the effort is the latest disappointment in two decades of trying to develop a microbicide — a cream or gel women could use to lower their risk of getting HIV through sex. A female-controlled method is especially needed in poor countries where women often can't persuade men to use condoms.
A year ago, scientists stopped two late-stage tests of a different gel after early results suggested it might raise the risk of HIV infection instead of lowering it. (...)
Click here to read the complete article.
Wednesday, February 06, 2008
Test Detects Sensitivity to HIV Drug
Source: US News & World Report
Test Detects Sensitivity to HIV Drug Could be first step toward personalized medicine, experts say
By Randy Dotinga
WEDNESDAY, Feb. 6 (HealthDay News) -- New research suggests that an expensive blood test could help a small minority of HIV patients discover whether they should avoid a common AIDS drug that can sometimes cause serious side effects.
The test detects sensitivity to the medication abacavir by checking to see if a patient's genetic makeup is linked to poor reactions to the medicine.
"This is very important news in relation to the great hopes from the work with the Human Genome Project," said Magnus Ingelman-Sundberg, a professor at Karolinska Institutet in Sweden, who wrote a commentary about the research. The genome project aims to analyze the genetic blueprint of humans.
At issue is the AIDS drug abacavir, also known by the brand name Ziagen, which is found in compound drugs known as Trizivir and Epzicom. The drug is known as a nucleoside reverse transcriptase inhibitor and works by preventing the AIDS virus from going through the motions of multiplying.
About 8 percent of patients suffer from hypersensitivity to the drug, said study author Simon Mallal, a researcher at Murdoch University & Royal Perth Hospital in Australia. His report on the results is published in the Feb. 7 issue of the New England Journal of Medicine. The problems typically occur within the first six weeks that patients use the drug, he added.
According to the study, the side effects include fever, rash, gastrointestinal symptoms and other problems.
By testing patients for a genetic trait that was found in 5.6 percent of 1,956 female and male patients, the researchers found they could spot potential cases of sensitivity to abacavir.
The test's use could allow doctors to do a better job of personalizing drugs for individual patients, Mallal noted. (...)
Click here to read the complete article
Test Detects Sensitivity to HIV Drug Could be first step toward personalized medicine, experts say
By Randy Dotinga
WEDNESDAY, Feb. 6 (HealthDay News) -- New research suggests that an expensive blood test could help a small minority of HIV patients discover whether they should avoid a common AIDS drug that can sometimes cause serious side effects.
The test detects sensitivity to the medication abacavir by checking to see if a patient's genetic makeup is linked to poor reactions to the medicine.
"This is very important news in relation to the great hopes from the work with the Human Genome Project," said Magnus Ingelman-Sundberg, a professor at Karolinska Institutet in Sweden, who wrote a commentary about the research. The genome project aims to analyze the genetic blueprint of humans.
At issue is the AIDS drug abacavir, also known by the brand name Ziagen, which is found in compound drugs known as Trizivir and Epzicom. The drug is known as a nucleoside reverse transcriptase inhibitor and works by preventing the AIDS virus from going through the motions of multiplying.
About 8 percent of patients suffer from hypersensitivity to the drug, said study author Simon Mallal, a researcher at Murdoch University & Royal Perth Hospital in Australia. His report on the results is published in the Feb. 7 issue of the New England Journal of Medicine. The problems typically occur within the first six weeks that patients use the drug, he added.
According to the study, the side effects include fever, rash, gastrointestinal symptoms and other problems.
By testing patients for a genetic trait that was found in 5.6 percent of 1,956 female and male patients, the researchers found they could spot potential cases of sensitivity to abacavir.
The test's use could allow doctors to do a better job of personalizing drugs for individual patients, Mallal noted. (...)
Click here to read the complete article
Drug Helps Prevent Breast-Feeding Moms From Passing on HIV
Source: US News and World Report
6 weeks of nevirapine greatly reduced infant infections in Africa, India, study found
Posted 2/6/08
WEDNESDAY, Feb. 6 (HealthDay News) -- The antiretroviral drug nevirapine greatly reduces the risk that HIV-infected mothers will pass the virus to their babies during breast-feeding, according to a study conducted in Africa and India.
Nevirapine is already in widespread use in developing countries to prevent HIV-positive women from infecting their newborns during childbirth, note researchers at Johns Hopkins University, in Baltimore.
In this study, the Hopkins team and colleagues in Ethiopia, India and Uganda gave daily doses of the drug to breast-feeding infants when they were 8 to 42 days old.
By the time they reached 6 weeks of age, the rate of HIV infection among infants who received the drug daily was about half that of infants who received a single dose of nevirapine at birth, which is the current standard of care.
After six months, the infants who'd received the six-week drug treatment were almost a third less likely to suffer HIV infection or death than those given the single dose at birth.
The study included about 2,000 infants and was conducted from 2001 to 2007. It's one of the first randomized controlled trials to show that a drug can prevent HIV transmission in infants being breast-fed by HIV-infected mothers.
The findings were presented Monday at the Conference on Retroviruses and Opportunistic Infections, in Boston.
Breast-feeding is a major cause of HIV infection in the developing world. Each year, about 150,000 infants are infected with HIV through breast-feeding, according to the World Health Organization.
6 weeks of nevirapine greatly reduced infant infections in Africa, India, study found
Posted 2/6/08
WEDNESDAY, Feb. 6 (HealthDay News) -- The antiretroviral drug nevirapine greatly reduces the risk that HIV-infected mothers will pass the virus to their babies during breast-feeding, according to a study conducted in Africa and India.
Nevirapine is already in widespread use in developing countries to prevent HIV-positive women from infecting their newborns during childbirth, note researchers at Johns Hopkins University, in Baltimore.
In this study, the Hopkins team and colleagues in Ethiopia, India and Uganda gave daily doses of the drug to breast-feeding infants when they were 8 to 42 days old.
By the time they reached 6 weeks of age, the rate of HIV infection among infants who received the drug daily was about half that of infants who received a single dose of nevirapine at birth, which is the current standard of care.
After six months, the infants who'd received the six-week drug treatment were almost a third less likely to suffer HIV infection or death than those given the single dose at birth.
The study included about 2,000 infants and was conducted from 2001 to 2007. It's one of the first randomized controlled trials to show that a drug can prevent HIV transmission in infants being breast-fed by HIV-infected mothers.
The findings were presented Monday at the Conference on Retroviruses and Opportunistic Infections, in Boston.
Breast-feeding is a major cause of HIV infection in the developing world. Each year, about 150,000 infants are infected with HIV through breast-feeding, according to the World Health Organization.
Moms Pre-Chewing Food Gave HIV to Kids
Source: The Associated Press
By MIKE STOBBE
ATLANTA (AP) — For the first time, health officials report that the AIDS virus can be spread by a mother pre-chewing her infant's food, a practice mainly seen in poor, developing countries.
Three such cases were reported in the United States from 1993-2004, government scientists said Wednesday in a presentation in Boston at a scientific conference.
It's blood, not saliva, that carried the virus because in at least two of the cases the infected mothers had bleeding gums or mouth sores, according to investigators at the U.S. Centers for Disease Control and Prevention.
CDC officials say more study is needed. But they are asking parents and caregivers with HIV not to pre-chew infants' food, and are trying to educate doctors about this kind of transmission.
Health officials believe chewed-food transmission is rare in the United States, where such behavior is considered unusual. In some countries, mothers do it because they have no access to baby food or a means of pulverizing food for toothless infants.
"But even one case is too many," said the CDC's Dr. Ken Dominguez, who helped investigate the U.S. cases. (...)
Click here to read the complete article.
By MIKE STOBBE
ATLANTA (AP) — For the first time, health officials report that the AIDS virus can be spread by a mother pre-chewing her infant's food, a practice mainly seen in poor, developing countries.
Three such cases were reported in the United States from 1993-2004, government scientists said Wednesday in a presentation in Boston at a scientific conference.
It's blood, not saliva, that carried the virus because in at least two of the cases the infected mothers had bleeding gums or mouth sores, according to investigators at the U.S. Centers for Disease Control and Prevention.
CDC officials say more study is needed. But they are asking parents and caregivers with HIV not to pre-chew infants' food, and are trying to educate doctors about this kind of transmission.
Health officials believe chewed-food transmission is rare in the United States, where such behavior is considered unusual. In some countries, mothers do it because they have no access to baby food or a means of pulverizing food for toothless infants.
"But even one case is too many," said the CDC's Dr. Ken Dominguez, who helped investigate the U.S. cases. (...)
Click here to read the complete article.
Tuesday, February 05, 2008
Circumcising HIV positive men may increase HIV infections in female partners, but fewer STIs seen
Source: AIDSMAP - 15th Conference on Retroviruses and Opportunistic Infections, Boston USA - February 2008
There was a trend towards higher HIV incidence in the wives of HIV positive men who were circumcised compared with wives of men left uncircumcised, in the latest prevention study conducted in Rakai province, Uganda, investigators revealed at a press conference on the opening day of the Fifteenth Conference on Retroviruses and Opportunistic Infections in Boston.
In 2006, a randomised trial of circumcision in Rakai reported that circumcision led to an almost 50% reduction in a man’s risk of acquiring HIV through heterosexual sex. The impact of male circumcision on transmission of HIV to the female partner remains unknown, and the study reported today set out to examine the effects.
In the Gates Foundation-funded study, 1015 HIV positive men were randomised either to immediate circumcision or circumcision delayed by two years. Of these 770 were married and were asked to invite their wives into the study; 566 wives enrolled of whom 245 (43%) were HIV-negative and therefore in a serodiscordant relationship.
The annual HIV incidence rate in the wives of the men who were circumcised was 14.4% over two years of follow-up compared with 9.1% in women whose partners remained uncircumcised. This result may be due to chance as it was not statistically significant, but was described as “unexpected and somewhat disappointing” by lead investigator Maria Wawer of Johns Hopkins University, Baltimore. It was not due to behavioural disinhibition; condom use was the same in both arms.
Wawer said that these results were an additional challenge to the rolling-out of mass circumcision programmes in Africa, which are expected following the positive results from three randomised controlled trials of circumcision in HIV negative men, one of them conducted within the Rakai community.
She said: “It is inevitable that some HIV positive men will seek circumcision. It is the only HIV prevention modality that leaves a mark, and no one wants to be the only guy in the village who is uncircumcised if it becomes regarded as a mark of HIV.” (...)
Click here to read the rest of the article.
There was a trend towards higher HIV incidence in the wives of HIV positive men who were circumcised compared with wives of men left uncircumcised, in the latest prevention study conducted in Rakai province, Uganda, investigators revealed at a press conference on the opening day of the Fifteenth Conference on Retroviruses and Opportunistic Infections in Boston.
In 2006, a randomised trial of circumcision in Rakai reported that circumcision led to an almost 50% reduction in a man’s risk of acquiring HIV through heterosexual sex. The impact of male circumcision on transmission of HIV to the female partner remains unknown, and the study reported today set out to examine the effects.
In the Gates Foundation-funded study, 1015 HIV positive men were randomised either to immediate circumcision or circumcision delayed by two years. Of these 770 were married and were asked to invite their wives into the study; 566 wives enrolled of whom 245 (43%) were HIV-negative and therefore in a serodiscordant relationship.
The annual HIV incidence rate in the wives of the men who were circumcised was 14.4% over two years of follow-up compared with 9.1% in women whose partners remained uncircumcised. This result may be due to chance as it was not statistically significant, but was described as “unexpected and somewhat disappointing” by lead investigator Maria Wawer of Johns Hopkins University, Baltimore. It was not due to behavioural disinhibition; condom use was the same in both arms.
Wawer said that these results were an additional challenge to the rolling-out of mass circumcision programmes in Africa, which are expected following the positive results from three randomised controlled trials of circumcision in HIV negative men, one of them conducted within the Rakai community.
She said: “It is inevitable that some HIV positive men will seek circumcision. It is the only HIV prevention modality that leaves a mark, and no one wants to be the only guy in the village who is uncircumcised if it becomes regarded as a mark of HIV.” (...)
Click here to read the rest of the article.
New Issue of JANAC received: Vol. 19, no 1, Jan/Feb 2008
The Journal of the Association of Nurses in AIDS Care covers the spectrum of nursing issues in HIV/AIDS: education, treatment, prevention, research, practice, clinical issues, awareness, policies and program development. This peer-reviewed journal is a forum for nurses and other health care professionals whose focus is the care and treatment of individuals infected and affected by HIV/AIDS.The Journal of the Association of Nurses in AIDS Care offers the latest information in the areas of health care delivery, program implementation and research analysis and application.
In this issue:
Editorial
Women and HIV Infection
Lucy Bradley-Springer
pages 1-2
Features
Low-Income HIV-Infected Women and the Process of Engaging in Healthy Behavior
Tracy A. Riley, Brenda M. Lewis, Mary Pat Lewis, Joseph L. Fava
pages 3-15
Abstract
Adaptation of an HIV Prevention Curriculum for Use With Older African American Women
Judith B. Cornelius, Linda Moneyham, Sara LeGrand
pages 16-27
Abstract
African American Women's Experience of Infection With HIV in the Rural Southeastern United States
Caroline Mallory
pages 28-36
Abstract
Health Concerns of Mature Women Living With HIV in the Midwestern United States
Maithe Enriquez, Nancy Lackey, Jacki Witt
pages 37-46
Abstract
Women's Voices: The Lived Experience of Pregnancy and Motherhood After Diagnosis With HIV
Lorraine B. Sanders
pages 47-57
Abstract
Improving Women's Adjustment to HIV Infection: Results of the Positive Life Skills Workshop Project
Carol Bova, Tobey Nestor Burwick, Maritza Quinones
pages 58-65
Abstract
The Centers for Disease Control and Prevention Revised Recommendations for HIV Testing: Reactions of Women Attending Community Health Clinics
Joe W. Burrage, Gregory D. Zimet, Dena S. Cox, Anthony D. Cox, Rose M. Mays, Rose S. Fife, Kenneth H. Fife
pages 66-74
Abstract
Promoting Adaptive Coping by Persons With HIV Disease: Evaluation of a Patient/Partner Intervention Model
Betsy L. Fife, Linda L. Scott, Naomi S. Fineberg, Beth E. Zwickl
pages 75-84
Abstract
Contact the library to request copies of articles.
Friday, February 01, 2008
Judge’s ignorance of AIDS draws fire
Source: The Toronto Star
Witness with HIV forced to wear a mask in court, groups complain
An Ontario judge is at the centre of a misconduct investigation after insisting a witness who is HIV-positive and has Hepatitis C don a mask while testifying in his courtroom.
Three groups have complained to the Ontario Judicial Council about the conduct of Barrie judge Justice Jon-Jo Douglas, who later moved the case to a bigger courtroom in order to create more distance between the witness and the bench. The judge refused to accept Crown counsel Karen McCleave's entreaties there was no need for such measures.
"The HIV virus will live in a dried state for year after year after year and only needs moisture to reactivate itself," Douglas insisted, according to a transcript of the Nov. 23 trial proceedings.
"This is outlandish," Bluma Brenner, an assistant professor at the McGill AIDS Clinic at McGill University in Montreal, said yesterday. A drop of human immunodeficiency virus drying on the floor "would be inactivated within 20 minutes," Brenner said in an interview.
But Douglas, a former Crown attorney appointed to the Ontario Court of Justice 10 years ago, was not prepared to continue the trial until he was satisfied "the safety and integrity of this courtroom" was protected.
"I mean, he speaks within two feet of me with two serious infectious diseases," Douglas told McCleave. "Either you mask your witness and/or move us to another courtroom or we do not proceed." (...)
Click here to read the article.
Witness with HIV forced to wear a mask in court, groups complain
An Ontario judge is at the centre of a misconduct investigation after insisting a witness who is HIV-positive and has Hepatitis C don a mask while testifying in his courtroom.
Three groups have complained to the Ontario Judicial Council about the conduct of Barrie judge Justice Jon-Jo Douglas, who later moved the case to a bigger courtroom in order to create more distance between the witness and the bench. The judge refused to accept Crown counsel Karen McCleave's entreaties there was no need for such measures.
"The HIV virus will live in a dried state for year after year after year and only needs moisture to reactivate itself," Douglas insisted, according to a transcript of the Nov. 23 trial proceedings.
"This is outlandish," Bluma Brenner, an assistant professor at the McGill AIDS Clinic at McGill University in Montreal, said yesterday. A drop of human immunodeficiency virus drying on the floor "would be inactivated within 20 minutes," Brenner said in an interview.
But Douglas, a former Crown attorney appointed to the Ontario Court of Justice 10 years ago, was not prepared to continue the trial until he was satisfied "the safety and integrity of this courtroom" was protected.
"I mean, he speaks within two feet of me with two serious infectious diseases," Douglas told McCleave. "Either you mask your witness and/or move us to another courtroom or we do not proceed." (...)
Click here to read the article.
HIV rate soars among Vancouver's native drug users
Source: The Globe & Mail
Startling new research reveals that aboriginal drug users living in Vancouver's Downtown Eastside are contracting HIV-AIDS at twice the rate of non-aboriginal users.
Over the four-year study, 18.5 per cent of aboriginal men and women who injected such drugs as cocaine and heroin became HIV-positive, compared with 9.5 per cent of non-aboriginal intravenous drug users.
"This is a tragedy," Evan Wood, a research scientist at the B.C. Centre for Excellence in HIV/AIDS, said in an interview. "Many people in the aboriginal community are reaching out for care and the care isn't there."
Dr. Wood, the lead author of the research, said the higher rates of infection among natives are not due to biological factors but rather to patterns of social networking: The fact that aboriginal people interact principally with other aboriginals heightens their exposure and speeds the spread of HIV-AIDS.
Better social programs tailored to aboriginals could help alleviate that situation, he said.
In fact, even before researchers started tracking new infections, they found that the proportion of aboriginal drug users with HIV-AIDS was already higher - 25.1 per cent versus 16 per cent for non-aboriginals. (...)
The entire article is available here.
Click here for an abstract of the research article.
Startling new research reveals that aboriginal drug users living in Vancouver's Downtown Eastside are contracting HIV-AIDS at twice the rate of non-aboriginal users.
Over the four-year study, 18.5 per cent of aboriginal men and women who injected such drugs as cocaine and heroin became HIV-positive, compared with 9.5 per cent of non-aboriginal intravenous drug users.
"This is a tragedy," Evan Wood, a research scientist at the B.C. Centre for Excellence in HIV/AIDS, said in an interview. "Many people in the aboriginal community are reaching out for care and the care isn't there."
Dr. Wood, the lead author of the research, said the higher rates of infection among natives are not due to biological factors but rather to patterns of social networking: The fact that aboriginal people interact principally with other aboriginals heightens their exposure and speeds the spread of HIV-AIDS.
Better social programs tailored to aboriginals could help alleviate that situation, he said.
In fact, even before researchers started tracking new infections, they found that the proportion of aboriginal drug users with HIV-AIDS was already higher - 25.1 per cent versus 16 per cent for non-aboriginals. (...)
The entire article is available here.
Click here for an abstract of the research article.
Briton sentenced to 14 years in prison for infecting women with HIV in Sweden
Source: The Canadian Press
STOCKHOLM, Sweden - A British man was sentenced Friday to 14 years in prison for infecting two young women with HIV and putting 13 more at risk of infection.
News agency TT reports that thirty-two-year-old Christer Aggett, also convicted of six counts of having sex with minors, was ordered to pay more than $428,000 in damages. The two HIV-infected women will receive the equivalent of about $134,000 - each. Aggett was charged in October with two counts of aggravated assault for allegedly infecting two girls during sex without telling them he was HIV-positive.
Solna District Court in November had found Aggett guilty of the charges but him to undergo psychiatric examination before sentencing. He also was charged with aggravated assault, or "exposing others to danger," by having unprotected sex with more than a dozen other women between 2001 and 2006 - six of them under the age of 15. They were not infected with HIV.
He confessed to most of the charges, but not to having had sex with underage girls, saying he was unaware they were so young. Aggett's lawyer, Jonas Granfelt, said his client is likely to appeal the ruling. Police suspect that Aggett had been in contact during the five-year period with at least 130 women he met via Internet chat rooms.
STOCKHOLM, Sweden - A British man was sentenced Friday to 14 years in prison for infecting two young women with HIV and putting 13 more at risk of infection.
News agency TT reports that thirty-two-year-old Christer Aggett, also convicted of six counts of having sex with minors, was ordered to pay more than $428,000 in damages. The two HIV-infected women will receive the equivalent of about $134,000 - each. Aggett was charged in October with two counts of aggravated assault for allegedly infecting two girls during sex without telling them he was HIV-positive.
Solna District Court in November had found Aggett guilty of the charges but him to undergo psychiatric examination before sentencing. He also was charged with aggravated assault, or "exposing others to danger," by having unprotected sex with more than a dozen other women between 2001 and 2006 - six of them under the age of 15. They were not infected with HIV.
He confessed to most of the charges, but not to having had sex with underage girls, saying he was unaware they were so young. Aggett's lawyer, Jonas Granfelt, said his client is likely to appeal the ruling. Police suspect that Aggett had been in contact during the five-year period with at least 130 women he met via Internet chat rooms.
Subscribe to:
Posts (Atom)
